Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

SABS

SAB Biotherapeutics, Inc.

Healthcare · USD

Set alert

Price alert · SABS

All alert types
3.35 USD +0.12 +3.72%
As of Oct 30, 2026 Extended hours 3.35 0.00%
Bid
3.34 × 5
Ask
3.36 × 2
3.11 Day range 3.37
2.49 52-week range 4.59
YTD
-10.43%
1 year
+11.30%
Open
3.20
Prev close
3.23
Mkt cap
304.80M
Vol
741.05K
Avg vol
536.84K
EPS
-1.29
P/E
0.00
Div yield
0.00%
More statistics
Low
3.11
High
3.37
Forward P/E
-1.56
Beta
0.64
Short ratio
1.22
Inst. own
34.25%
Dividend
0.00
Ex-div date
Earnings
Aug 8, 2024
50-d avg
3.29
200-d avg
3.35
1y target
12.40

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for SABS has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

7.22 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B3 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 4
  • P/B 4

Valuation

P/E 17.0×
FY 2019: -461×FY 2020: 13.6×FY 2021: -12.4×FY 2022: -1.4×FY 2023: -0.9×FY 2024: -1.0×FY 2025: 17.0×
FY 2019 5y median -1.0× FY 2025
P/S 0.0×
FY 2019: 128×FY 2020: 5.0×FY 2021: 3.5×FY 2022: 1.1×FY 2023: 17.0×FY 2024: 26.5×FY 2025: 0.0×
FY 2019 5y median 3.5× FY 2025
P/B 0.5×
FY 2019: -191×FY 2020: 7.0×FY 2021: 5.5×FY 2022: 0.8×FY 2023: 0.7×FY 2024: 1.4×FY 2025: 0.5×
FY 2019 5y median 0.8× FY 2025
P/FCF -1.6×
FY 2019: -44.9×FY 2020: -101×FY 2021: -23.8×FY 2022: -1.0×FY 2023: -1.5×FY 2024: -1.0×FY 2025: -1.6×
FY 2019 5y median -1.5× FY 2025
EV/EBITDA 4.1×
FY 2019: -53.7×FY 2020: 12.8×FY 2021: -12.4×FY 2022: -1.1×FY 2023: 0.3×FY 2024: -1.1×FY 2025: 4.1×
FY 2019 5y median -1.1× FY 2025
EV/Sales 0.0×
FY 2019: 129×FY 2020: 4.9×FY 2021: 3.1×FY 2022: 0.7×FY 2023: -5.7×FY 2024: 23.3×FY 2025: 0.0×
FY 2019 5y median 0.7× FY 2025
FCF Yield -63.3%
FY 2019: -2.2%FY 2020: -1.0%FY 2021: -4.2%FY 2022: -99.8%FY 2023: -66.6%FY 2024: -98.7%FY 2025: -63.3%
FY 2019 5y median -66.6% FY 2025

Profitability

Gross Margin 0.0%
FY 2019: 100.0%FY 2020: 100.0%FY 2021: 97.3%FY 2022: 86.2%FY 2023: -67.3%FY 2024: -262.4%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2019: -252.0%FY 2020: 37.2%FY 2021: -22.0%FY 2022: -121.0%FY 2023: -1700.5%FY 2024: -3244.9%FY 2025: 0.0%
FY 2019 5y median -121.0% FY 2025
Net Margin 0.0%
FY 2019: -261.1%FY 2020: 36.4%FY 2021: -28.2%FY 2022: -78.4%FY 2023: -1884.5%FY 2024: -2579.0%FY 2025: 0.0%
FY 2019 5y median -78.4% FY 2025
ROE 8.8%
FY 2019: 389.8%FY 2020: 51.6%FY 2021: -44.5%FY 2022: -60.3%FY 2023: -73.6%FY 2024: -131.3%FY 2025: 8.8%
FY 2019 5y median -60.3% FY 2025
ROIC -30.0%
FY 2019: -56.6%FY 2020: 43.6%FY 2021: -23.2%FY 2022: -77.5%FY 2023: -50.8%FY 2024: -115.9%FY 2025: -30.0%
FY 2019 5y median -50.8% FY 2025
ROA 7.7%
FY 2019: -49.9%FY 2020: 35.6%FY 2021: -21.1%FY 2022: -36.8%FY 2023: -50.3%FY 2024: -77.2%FY 2025: 7.7%
FY 2019 5y median -36.8% FY 2025

Growth (YoY)

Revenue -100.0%
FY 2019: 0.0%FY 2020: 1504.8%FY 2021: 10.2%FY 2022: -60.7%FY 2023: -90.6%FY 2024: -40.9%FY 2025: -100.0%
FY 2019 FY 2025
Operating Income -14.1%
FY 2019: 0.0%FY 2020: 337.0%FY 2021: -165.2%FY 2022: -115.9%FY 2023: -31.7%FY 2024: -12.7%FY 2025: -14.1%
FY 2019 FY 2025
EPS (diluted) 78.5%
FY 2019: 0.0%FY 2020: 3486.4%FY 2021: -184.6%FY 2022: 31.6%FY 2023: -77.3%FY 2024: 51.8%FY 2025: 78.5%
FY 2019 FY 2025
Free Cash Flow -32.0%
FY 2019: 0.0%FY 2020: 72.2%FY 2021: -228.5%FY 2022: -186.1%FY 2023: 1.2%FY 2024: -36.8%FY 2025: -32.0%
FY 2019 FY 2025

Financial Health

Current Ratio 9.5×
FY 2019: 2.0×FY 2020: 3.1×FY 2021: 1.9×FY 2022: 1.5×FY 2023: 5.4×FY 2024: 3.0×FY 2025: 9.5×
FY 2019 5y median 3.0× FY 2025
Quick Ratio 9.5×
FY 2019: 2.0×FY 2020: 3.1×FY 2021: 1.9×FY 2022: 1.5×FY 2023: 5.4×FY 2024: 3.0×FY 2025: 9.5×
FY 2019 5y median 3.0× FY 2025
Debt / Equity 0.0×
FY 2019: -3.3×FY 2020: 0.2×FY 2021: 0.2×FY 2022: 0.2×FY 2023: 0.1×FY 2024: 0.2×FY 2025: 0.0×
FY 2019 5y median 0.2× FY 2025
Net Debt / EBITDA -0.3×
FY 2019: -0.2×FY 2020: -0.2×FY 2021: 1.6×FY 2022: 0.6×FY 2023: 1.3×FY 2024: 0.1×FY 2025: -0.3×
FY 2019 5y median 0.6× FY 2025
Interest Coverage -203×
FY 2019: -20.2×FY 2020: 43.8×FY 2021: -45.5×FY 2022: -95.9×FY 2023: -121×FY 2024: -135×FY 2025: -203×
FY 2019 5y median -121× FY 2025

Dividends

Dividend Yield 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31